N/A
N=200
Telephonic Contact and Subsequent Physical Follow up Treated Lung Cancer Patients
Lung Cancer
Bottom Line
View on ClinicalTrials.gov: NCT01133067 ↗Enrolled (actual)
200
Serious AEs
0.0%
Results posted
Aug 2018
Primary outcome: Primary: Concurrence Between the Telephonic Interview and the Physician Assessment — 0.64 probability
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Tata Memorial Hospital
- Primary completion
- Jul 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Concurrence Between the Telephonic Interview and the Physician Assessment |
0.64 | — |
| SECONDARY Cost Analysis |
5117.10; 3079.06 | — |
Summary
Does the routine clinical practice of follow up after primary treatment in lung cancer patients has any utility.
Eligibility Criteria
Inclusion Criteria
- All patients of lung cancer treated with a radical aim (e.g surgery, Chemoradiation, surgery followed by adjuvant treatment or any other combination)
- Patients should have completed radical /adjuvant treatment, if any
- Patients of both SCLC and NSCLC
- Patients with at least two telephone numbers (landline/mobile/both)
- Patients willing to participate
Exclusion Criteria
- All patients for palliative intention
- Patients with less than two contact telephone numbers -
Data sourced from ClinicalTrials.gov (NCT01133067). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.